Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Acquisition, analysis, or interpretation of data: H.S.B., C.J., Y.Y., J.L., J.L., E.Y.L
Report of a large clinical trial showing the efficacy of a passively administered, half-life-extended, second-generation human nAb to protect infants from RSV disease
doi:10.1172/JCI123089
Other ingredients discovered by the FDA include phenolphthalein, blood pressure treatments, seizure medications, and other mislabeled products
I understand Kaiser removed these from base coverage in 2025, but some employers opted to add this benefit
M.ZiliotisM
US$ 27.88
US$ 26.20
US$ 29.49
US$ 27.37
US$ 21.81
US$ 21.07
